Unlike lymphoma, EZH2 mutations in AML tend to be loss-of-function mutations [15], and studies indicate that loss-of-function EZH2 mutations in AML patients have poor prognoses and are associated with a reduced overall survival [16,17]. Here, EZH2 is linked to acute myeloid leukemia.